Physician profile
Javier M Bibb
NPI 1871513358
$1,661.94
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $187 · 2021: $188 · 2022: $254 · 2023: $19.79 · 2024: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $339.73 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $203.96 | 2019-2022 | |
| Outset Medical INC | $178.66 | 2024 | |
| Calliditas Therapeutics US INC. | $115.64 | 2024 | |
| Opko Pharmaceuticals, LLC | $107.02 | 2019-2022 | |
| Genzyme Corporation | $104.15 | 2019 | |
| Akebia Therapeutics INC | $68.26 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.45 | 2021-2022 | |
| Vifor Pharma, INC. | $62.04 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.79 | 2022 | |
| Mallinckrodt Hospital Products INC. | $53.45 | 2021 | |
| Aurinia Pharma U.S., INC. | $50.43 | 2021-2022 | |
| Boston Scientific Corporation | $44.39 | 2023-2024 | |
| Genentech USA, INC. | $39.55 | 2019 | |
| Horizon Therapeutics Plc | $35.01 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $33.34 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $27.46 | 2019-2020 | |
| Veloxis Pharmaceuticals, INC. | $23.11 | 2022 | |
| Mallinckrodt Enterprises LLC | $20.86 | 2019 | |
| Alnylam Pharmaceuticals INC. | $19.87 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Bibb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.